Intrarenal renin-angiotensin system — important player of the local milieu

Lansang M. , Price D. , Laffel L. et al. Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. Kidney Int 2001;59:1432-8.

Navar L. The intrarenal renin-angiotensin system in hypertension. Kidney Int 2004;65:1522-32.

Navar L. , Harrison-Bernard L. , Nishiyama A. , Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002;39:316-22.

Kobori H. , Nishiyama A. , Abe Y. , Navar L. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 2003;41:529-97.

Kobori H. , Prieto-Carrasquero M. , Ozawa Y. , Navar L. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 2004 ;43:1126-32.

Nishiyama A. , Seth D. , Navar L. Renal interstitial concentrations of angiotensins I and II in anesthestized rats. Hypertension 2002;39:129-34.

Navar LG , Imig JD , Zou L. , Wang C-T. Intrarenal production of angiotensin II. Sem Nephrol 1997;17:412-22.production

Ingelfinger J. , Zuo WM , Fon EA , Ellison KE , Dzau VJ In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. J Clin Invest 1990;85:417-23.

Kobori H. , Harrison-Bernard LM , Navar LG Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production . Hypertension 2003;41(1): 42-9.

Liebau MC , Lang D. , Bohm J. et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol 2006 ;290(3):F710-F719.

Navar LG , Harrison-Bernard LM , Imig JD Compartmentalization of intrarenal angiotensin II. In: Ulfendahl HR, Aurell M, eds. Renin-Angiotensin. London: Portland Press; 1998:193-208.

Wilcox CS , Dzau VJ Effect of captopril on the release of the components of the renin-angiotensin system into plasma and lymph. J Am Soc Nephrol 1992;2:1241-50.

Cowley AW Jr , Mori T. , Mattson D. , Zou A-P. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regulatory Integrative Comp Physiol 2003; 284(6):R1355-R1369.

Navar L. , Inscho E. , Majid S. , Imig J. , Harrison-Bernard L. , Mitchell K. Paracrine regulation of the renal microcirculation. Physiol Rev 1996;76:425-536.

Paxton WG , Runge M. , Horaist C. , Cohen C. , Alexander RW , Bernstein KE Immunohistochemical localization of rat angiotensin II AT1 receptor . Am J Physiol-Renal Physiol 1993;264:F989-F995.

DiBona GF Dynamic analysis of patterns of renal sympathetic nerve activity: implications for renal function. Exp Physiol 2005;90(2):159-61.

Miyata N. , Park F. , Li XF , Cowley Jr AW Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney . Am J Physiol-Renal Physiol 1999;277:F437-F446.

Haller H. , Lindschau C. , Erdmann B. , Quass P. , Luft FC Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res 1996;79:765-72.

Anderson KM , Peach MJ Receptor binding and internalization of a unique biologically active angiotensin II-colloidal gold conjugate: Morphological analysis of angiotensin II processing in isolated vascular strips. J Vasc Res 1994;31:10-17.

Re R. The nature of intracrine peptide hormone action. Hypertension 1999;34:534-8.

Chen R. , Mukhin YV , Garnovskaya MN et al. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol-Renal Physiol 2000;279:F440-F44.

Loghman-Adham M. , Soto CE , Inagami T. , Cassis L. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol 2004;287(4):F775-F788.

Almeida WS , Maciel TT , Di Marco GS , Casarini DE , Campos AH , Schor N. Escherichia coli lipopolysaccharide inhibits renin activity in human mesangial cells. Kidney Int 2006;69(6):974-80.

Graciano ML , de Cassia Cavaglieri R. , Dellê H. et al. Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 2004;15:1805-15.

Carey RM , Siragy HM The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 2003;14(6):274-81.

Hollenberg NK , Price DA , Fisher ND et al. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus . Kidney Int 2003;63 (1):172-8.

Chan LY , Leung JC , Tang SC , Choy CB , Lai KN Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol 2005;16(8):2306-17.

Alexander RW Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995;25: 155-61.

Sen CK , Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-20.

Khan BV , Harrison DG , Olbrych MT , Alexander RW , Medford RM Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells . Proc Natl Acad Sci USA. 1996;93:9114-19.http://hyper. ahajournals.org/cgi/ijlink?linkType=ABST&journalCode=p nas&resid=93/17/9114

Barnes PJ , Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;33:1066-71.

Ushio-Fukai M. , Alexander RW , Akers M. , Griendling KK p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy . J Biol Chem 1998;273:15022-9.

Luft FC , Mervaala E. , Muller DN et al. Hypertension-induced end-organ damage: A new transgenic approach to an old problem. Hypertension 1999;33(1 Pt 2):212-18.

Nishiyama A. , Seth DM , Navar LG Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 2002;39:129-34.

Parving HH , Lehnert H. , Brochner-Mortensen J. , Gomis R. , Andersen S. , Arner P. Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345(12): 870-8.

Rossing K. , Schjoedt KJ , Jensen BR , Boomsma F. , Parving HH Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int 2005;68(3):119D0-8.

Russo D. , Minutolo R. , Pisani A. et al. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 2001;38(1): 18-25.

Azizi M. , Webb R. , Nussberger I.J. , Hollenberg NK Renin inhibition with aliskiren: where are we now, and where are we going? J Hypertens 2006;24(2):243-56.